Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXIMAB-PVVR for Encephalitis autoimmune: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 15 adverse event reports in the FDA FAERS database where RITUXIMAB-PVVR was used for Encephalitis autoimmune.

Most Reported Side Effects for RITUXIMAB-PVVR

Side Effect Reports % Deaths Hosp.
Off label use 2,079 49.4% 209 502
Intentional product use issue 627 14.9% 56 146
Condition aggravated 514 12.2% 26 147
Death 338 8.0% 338 63
Covid-19 322 7.7% 39 135
Fatigue 318 7.6% 15 84
Dyspnoea 314 7.5% 27 104
Inappropriate schedule of product administration 311 7.4% 21 77
Headache 291 6.9% 8 77
Pruritus 288 6.8% 4 35
Nausea 286 6.8% 8 76
Malaise 275 6.5% 28 95
Pain 271 6.4% 13 79
Throat irritation 259 6.2% 1 30
Cough 249 5.9% 15 64

Other Indications for RITUXIMAB-PVVR

Rheumatoid arthritis (1,659) Granulomatosis with polyangiitis (745) Microscopic polyangiitis (174) Multiple sclerosis (106) Systemic lupus erythematosus (105) Interstitial lung disease (73) Glomerulonephritis membranous (65) Anti-neutrophil cytoplasmic antibody positive vasculitis (62) Sjogren's syndrome (54) Product used for unknown indication (52)

Other Drugs Used for Encephalitis autoimmune

RITUXIMAB (524) METHYLPREDNISOLONE (332) HUMAN IMMUNOGLOBULIN G (314) PREDNISONE (100) CYCLOPHOSPHAMIDE (81) LEVETIRACETAM (75) PREDNISOLONE (64) MYCOPHENOLATE MOFETIL (61) IMMUNE GLOBULIN NOS (52) BORTEZOMIB (46)

Related Pages

RITUXIMAB-PVVR Full Profile All Encephalitis autoimmune Drugs RITUXIMAB-PVVR Demographics RITUXIMAB-PVVR Timeline